Efficacy of a teledentistry-based follow-up approach for monitoring oral health in patients with head and neck cancer after radiotherapy: a noninferiority randomized controlled trial Authors: Sungkrit Pojmonpiti, Wisunee Witthayawarakul, Todsaporn Fuangrod, Supakorn Suntornchatchaweach Published: 2026 ABSTRACT ObjectiveTo evaluate the efficacy of a teledentistry-based follow-up approach compared with standard in-person follow-up for monitoring oral health among patients with head and neck cancer (HNC) after the completion of radiotherapy, using a noninferiority framework.MethodsIn this two-arm, noninferiority randomized controlled trial, teledentistry was compared with standard in-person follow-up in patients with HNC after the completion of radiotherapy. The participants were randomized 1:1 and followed up at 1, 3, and 6 months. For teledentistry, a secure digital platform incorporating live video and self-photography was used. The primary outcomes were the percentage of tooth surfaces with plaque (plaque index) and bleeding on probing. The secondary outcomes were radiotherapy-related oral complications (i.e., dental caries incidence, trismus assessed via maximal mouth opening, mucositis severity, xerostomia severity, and osteoradionecrosis incidence) and patient-reported measures, including oral health–related quality of life (Oral Health Impact Profile, OHIP-14) and patient satisfaction. Noninferiority was assessed using analysis of covariance and risk difference calculations, comparing outcomes between groups based on data collected 2 weeks after the 6-month follow-up. A predefined noninferiority margin of 15%, representing the maximum clinically acceptable difference between groups, was applied with 95% confidence intervals (CI).ResultsTwenty-seven participants completed the study (teledentistry group: n = 14; standard group: n = 13), with no statistically significant baseline differences. Teledentistry was noninferior to standard follow-up for the plaque index (mean difference: 1.9% points; 95% CI [− 8.6, 12.4]) and bleeding on probing (mean difference: −2.2% points; 95% CI [− 17.2, 12.8]). The incidence of osteoradionecrosis was also noninferior (risk difference: −0.15; 95% CI [− 0.35, 0.04]). Patient satisfaction was high across the groups. Outcomes related to other radiotherapy-related oral complications and oral health–related quality of life were inconclusive.ConclusionTeledentistry appears to be a feasible and noninferior follow-up modality for patients with HNC during the initial 6 months after radiotherapy.Trial registrationTCTR20221008001, registered on October 8, 2022.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12903-026-08938-8. Introduction Head and neck cancer (HNC) is the seventh most prevalent malignancy globally and is among the five most common cancers in Thailand [1, 2]. Although its incidence continues to rise, advances in treatment have improved survival rates [1]. Radiotherapy remains a cornerstone treatment; however, it often negatively affects oral health due to radiation exposure [3–5]. Hence, a comprehensive dental assessment should be performed, and a treatment plan should be formulated before starting radiotherapy [3–5]. Regular post-treatment oral health monitoring is also necessary to minimize the risk of complications [3–5]. Oral healthcare is a critical component of survivorship care in HNC. It generally includes maintaining oral hygiene and monitoring radiotherapy-related oral complications and adverse effects. Patients who receive consistent dental care have better survival outcomes than those who do not [6]. In patients who have undergone radiotherapy for HNC, this treatment is associated with a wide range of oral complications, including mucositis, dry mouth, trismus, dental caries, and osteoradionecrosis. Dry mouth is one of the most common and persistent complications, resulting from radiation-induced salivary gland dysfunction, with evidence showing that stimulated salivary flow can decrease by more than 50% within the first 6 months after radiotherapy [7]. This reduction in salivary function contributes to an increased risk of dental caries, affecting around 29% of patients following radiotherapy [8]. At this time point, about 8% of patients still exhibit oral mucositis, including cases with ulceration [7]. Trismus is another common and functionally significant complication, with prevalence reaching up to 44% and remaining persistent in around 32% of patients long term [9]. Osteoradionecrosis, although less common, remains a serious late complication, with an estimated incidence of approximately 5% in the modern radiotherapy era [10]. Collectively, these complications can impair oral health, function, and quality of life. Current cancer guidelines recommend regular follow-up at intervals of every 1–3 months during the first year, every 2–6 months in the second year, and every 4–8 months from years 3 to 5, primarily to detect cancer recurrence [11, 12]. Given the high prevalence and persistence of radiotherapy-related oral complications, follow-up also plays a critical role in ongoing oral healthcare. Frequent oral health monitoring is essential to detect early signs of complications, reinforce preventive measures, and provide timely management through clinical and oral hygiene assessments [4, 5]. In practice, oral health follow-up is typically recommended every three to six months after radiotherapy, with more frequent visits during the early post-treatment period due to the dynamic progression and recovery of oral conditions [4, 5]. However, regularly attending in-person follow-up visits can impose substantial burdens on patients and their families, including time, travel, and financial costs, particularly during this early phase when visits are most frequent. Telehealth has emerged as a promising tool for improving healthcare access for cancer survivors by offering an alternative to attending in-person appointments [13, 14]. In addition, it can help alleviate the effects of healthcare workforce shortages and reduce patient costs, which can be critical issues in remote and underserved areas [15]. In dentistry, the advent of telehealth has given rise to teledentistry—a technology-driven approach that enables remote dental care via video consultations and photographic assessments [16]. Despite its potential, teledentistry has not been widely adopted, largely due to a lack of robust evidence guiding its clinical implementation [17]. In telehealth research, noninferiority analyses are performed to determine whether a new approach, which may offer additional benefits (e.g., shorter travel time or lower cost), provides care that is not unacceptably worse than standard methods. Importantly, the failure to demonstrate superiority does not imply equivalence; rather, it indicates insufficient evidence to conclude that one method is better than the other [18]. Therefore, we conducted a randomized controlled trial (RCT) to determine whether teledentistry is noninferior to standard in-person dental follow-up in terms of oral health outcomes, specifically plaque index (PI) and bleeding on probing (BOP), in patients with HNC following the completion of radiotherapy, with follow-up scheduled at 1, 3, and 6 months. This timeframe was selected to capture the early post-radiotherapy phase, during which oral complications are most dynamic and follow-up intensity is highest. Our findings support teledentistry as an alternative approach for delivering high-quality oral health services to HNC survivors while reducing in-person follow-up visits, and they have implications for the development of care. Methods Study design and participants This study was a two-arm RCT with a noninferiority design. From June 2022 to March 2023, patients who provided written informed consent and met the inclusion criteria were enrolled in the study. Patients who had recently completed radiotherapy for cancer at Chulabhorn Hospital that targeted the head and neck region, had no metastasis, had no history of radiotherapy prior to what they received at Chulabhorn Hospital, had ≥ 10 remaining teeth, and were ≥ 18 years of age were eligible for the study. Patients who were receiving palliative cancer care, had communication difficulties, or had no internet access (for the teledentistry service) were excluded. Moreover, all included participants had undergone dental assessment and treatment planning at the Chulabhorn Hospital dental clinic before and during radiotherapy and had received appropriate dental treatment (e.g., dental fillings for all carious lesions and scaling and/or root planing for gingivitis and/or periodontitis) [4]. Participants were randomly assigned to one of two groups: the teledentistry group or the standard group. Randomization was performed using a 1:1 allocation ratio and random block sizes of two and four, and the sequences were independently generated using Microsoft Excel v16 (Microsoft, Redmond, WA, USA). Research Electronic Data Capture (REDCap), hosted at Chulabhorn Royal Academy, was used for the allocation and data collection [19]. Ethics The study protocol was approved by Chulabhorn Research Institute’s Ethics Committee and Chulabhorn Royal Academy’s Institutional Review Board (Project Code 180/2564), and written informed consent was obtained from all participants. The trial was registered in the Thai Clinical Trials Registry (TCTR20221008001) and recorded retrospectively on October 8, 2022, after participant enrollment. The delay in registration was due to the research team’s initial unfamiliarity with the clinical trial registration requirements; however, the study protocol, including all predefined endpoints and the randomization design, had been finalized before the trial commenced and was not modified after enrollment began. This report follows the Consolidated Standards of Reporting Trials (CONSORT) extension for noninferiority randomized trials [20]. Sample size calculation The sample size was calculated based on a noninferiority RCT design using 6-month PI and BOP as the primary outcomes with a 15% noninferiority margin. Based on a reference study [21], and assuming a 95% confidence interval (CI) and 80% power, the required sample size was at least 28 participants (14 per group). Intervention Following randomization, both groups of participants attended follow-up visits at 1, 3, and 6 months after the completion of radiotherapy. During these follow-up visits, participants in both groups received standardized care, including oral hygiene instructions (use of appropriate tooth-cleaning tools and fluoride-containing products), monitoring for radiotherapy-related oral complications, and individualized self-management advice. Specifically, patients were advised, and their self-care practices were evaluated, to maintain oral hygiene through gentle toothbrushing using sodium lauryl sulfate (SLS)-free fluoride-containing toothpaste and adjunctive neutral fluoride products to prevent dental caries. They were also instructed to manage mucositis through adequate hydration and avoidance of irritants (e.g., alcohol-containing mouthwashes and spicy foods); to alleviate xerostomia with frequent sips of water and the use of saliva substitutes; to perform regular jaw-opening exercises to prevent or reduce trismus; and to minimize the risk of osteoradionecrosis by avoiding oral trauma, maintaining optimal oral health, and promptly reporting any signs of exposed bone or non-healing lesions. These recommendations were provided in accordance with the guidelines of The Royal College of Surgeons of England and the British Society for Disability and Oral Health [4]. All follow-ups and clinical advice were provided by the same general dentist (SP) under the supervision of a dental specialist (WW). Throughout the follow-up period, the participants were permitted to contact the dentists (SP and WW) between their scheduled visits. The follow-up visits were delivered differently between groups: the standard group received follow-up through in-person visits at the dental clinic, whereas the teledentistry group received care remotely using both synchronous (live video) and asynchronous (self-photography using a smartphone) methods. The Myoncare (ONCARE GmbH, Munich, Germany) platform was used for live video consultations and for sharing self-photographs, as it emphasizes data protection and security. The participants submitted their images via the Myoncare platform at each follow-up visit. No specific smartphone model was required, and participants used their own devices; caregivers were allowed to assist with image acquisition when necessary. To ensure that participants submitted consistent and clinically usable images, they were instructed by the dentists (SP and WW) during the enrollment period, through both verbal guidance and a leaflet, to follow a standardized procedure [22]. This involved turning on the phone’s flash, setting the image format to 9:16, positioning themselves in front of a mirror, holding the phone horizontally, and aligning the phone with the oral cavity. A total of 15 images were captured, comprising extraoral facial views with the mouth closed and maximally open, four tongue views (protruded, elevated, left lateral, and right lateral), intraoral views of the upper and lower inner lips, left and right buccal mucosa, full maxillary and mandibular dentition, and frontal and bilateral lateral occlusal views. When necessary, simple accessories (e.g., a spoon handle) were used to retract the cheeks to enhance visualization of posterior areas. The participants were asked to submit their self-photographs 1–2 days before the scheduled video consultation to allow for image quality review. The submitted images were reviewed by SP and WW prior to each consultation. The purpose of image review was to assess image quality and adequacy for clinical interpretation, as well as to screen for visible oral conditions, including mucosal changes, dental plaque accumulation, and other radiotherapy-related oral complications. If the images were of insufficient quality, participants were asked to recapture them before the consultation or were guided during the consultation to obtain usable images. The findings of image review were used to guide individualized advice and were not subjected to formal analysis. Data collection and outcome measures The primary outcomes of this study were two oral health indicators: PI and BOP, which were used to assess oral hygiene status and gingival inflammation, respectively. The secondary outcomes were radiotherapy-related oral complications (i.e., dental caries incidence, trismus assessed via maximal mouth opening, mucositis severity, xerostomia severity, and osteoradionecrosis incidence) and self-reported subjective measures, including oral health–related quality of life and patient satisfaction. Data collection was conducted at baseline (within 1 week after completing radiotherapy) and 2 weeks after the 6-month follow-up visit at the dental clinic (i.e., participants in both the teledentistry and standard groups attended the dental clinic). Clinical assessments at both time points were performed by an experienced examiner (SS), who was blinded to group allocation. Participants were pre-allocated to be assessed by either SP or WW. To maintain blinding, participants were instructed not to disclose their group assignment to the assessing dentist (SS). The clinical examination protocol was standardized for both groups, and no teledentistry-related materials or discussion occurred during the assessment visit. Participants’ characteristics, including age, sex, marital status, healthcare scheme (i.e., type of health insurance coverage: Civil Service Medical Benefits Scheme, Social Security Scheme, and Universal Coverage Scheme), tumor stage, tumor site, total radiation dose, cancer treatment regimen, number of remaining teeth, and severity of radiotherapy-related oral complications (i.e., mucositis, xerostomia, and trismus), were also collected at baseline by SS. Regarding the clinical assessments, PI was measured by recording the presence or absence of dental plaque at four surfaces (buccal, mesial, distal, and lingual) of each tooth following application of a disclosing agent (6% erythrosine solution) [23]. BOP was recorded dichotomously (presence/absence) at the same four surfaces per tooth following gentle probing of the gingival sulcus [24]. The percentage of tooth surfaces with plaque or bleeding (for PI and BOP, respectively) was calculated by dividing the number of affected surfaces by the total number of available surfaces. Dental caries was assessed clinically using visual–tactile examination based on established diagnostic criteria, guided by the International Caries Detection and Assessment System (ICDAS) [25]. Maximal mouth opening was measured in millimeters as the maximum interincisal distance using a ruler [26]. Mucositis and xerostomia were graded using the Common Terminology Criteria for Adverse Events (CTCAE v3.0) based on clinical signs and patient-reported symptoms, with severity classified as grade 0 (none), grade I (mild), grade II (moderate), grade III (severe), and grade IV (life-threatening; mucositis only) [27]. Osteoradionecrosis was diagnosed clinically based on the presence of exposed bone or non-healing lesions in previously irradiated areas [28]. Dental caries and osteoradionecrosis were confirmed by radiographic examination (panoramic and bitewing radiographs) and analyzed as incidence outcomes. Changes in maximal mouth opening, mucositis, and xerostomia were analyzed as binary outcomes, categorized as worsening or no worsening. Worsening was defined as a decrease in maximal mouth opening of ≥ 1 mm from baseline or an increase of ≥ 1 grade in mucositis or xerostomia severity. Although progression of mucositis after completion of radiotherapy may be uncommon, worsening mucositis severity was included as an exploratory outcome because exacerbation may still occur due to oral infection or poor oral health, particularly among participants receiving concurrent chemotherapy. For the self-reported subjective measures, the Thai version of the 14-item Oral Health Impact Profile (OHIP-14) was used to determine oral health–related quality of life [29]. The OHIP-14 includes 14 items, each rated on a five-point Likert scale (0–4). The total score ranges from 0 to 56, with higher scores indicating a greater negative impact on oral health–related quality of life [29, 30]. The OHIP-14 demonstrated good reliability (Cronbach’s α = 0.88) and acceptable validity [30, 31]. Patient satisfaction was assessed using a single-item questionnaire routinely implemented in the clinical workflow at Chulabhorn Hospital. Participants rated the question, “How satisfied are you with the dental services you received?”, on a five-point Likert scale. Both self-reported measures were completed by participants using hardcopy questionnaires. Statistical analysis Data were analyzed using SPSS v29 (IBM, Armonk, NY, USA). Baseline characteristics were compared between the groups using independent t-tests for continuous variables and Fisher’s exact test for categorical variables. Outcomes were analysed for noninferiority using a 95% CI. Analysis of covariance (ANCOVA) was performed to compare the mean PI, BOP, and OHIP-14 scores at the post 6-month follow-up visit, adjusting for baseline values and applying a 15% absolute-difference margin. For OHIP-14, scores were converted to percentages of the maximum score to enable application of the predefined noninferiority margin. Risk differences were calculated for radiotherapy-related complications. A 15% proportional change margin was applied in the analysis of risk differences. In noninferiority analyses, the CI is the primary determinant of interpretation. A CI crossing zero does not indicate equivalence; the key criterion is whether the entire CI remains within the prespecified noninferiority margin. If any part of the CI extends beyond this margin, noninferiority cannot be claimed. Only when the full CI is contained within the margin can noninferiority be concluded [20]. A 15% margin was selected based on clinical judgment and prior literature, representing the maximum difference that would be considered clinically acceptable without compromising patient care. Specifically, this margin reflects a difference unlikely to result in clinically meaningful deterioration in oral health outcomes or to alter clinical management (e.g., escalation from scaling for gingivitis to root planing for periodontitis) [21, 32]. For OHIP-14, an additional descriptive analysis of clinically meaningful change was conducted using a 10-point threshold (improvement: decrease ≥ 10; worsening: increase ≥ 10; otherwise stable), guided by the concept of the minimally important difference [33]. This analysis was performed for descriptive purposes only and was not used for inferential comparisons. Results Figure 1 shows the study flowchart, which was prepared in accordance with the CONSORT guidelines. Among the 28 participants, 27 completed all follow-up visits: 14 in the teledentistry group (mean age: 50.4 ± 14.2 years) and 13 in the standard group (mean age: 49.9 ± 15.7 years). One participant in the standard group died during the second month from a cause unrelated to the study and was excluded from the per-protocol analysis. Fig. 1CONSORT flow diagram CONSORT flow diagram Most participants received high-dose radiotherapy, with 78.6% of the participants in the teledentistry group and 84.6% of the participants in the standard group receiving doses > 60 Gy. The tumors were predominantly located in the nasopharynx, and most were classified as stage III or IV according to the American Joint Committee on Cancer’s Cancer Staging Manual (seventh edition) [34]. At baseline, the prevalence and severity of oral mucositis were similar between groups, with most cases classified as grade I–II (71.4% and 76.9% in the teledentistry and standard groups, respectively). Xerostomia was also common in both groups, predominantly grade II. Overall, baseline characteristics did not differ significantly between groups (Table 1), indicating that the groups were comparable at enrollment. Table 1Baseline characteristics of the study participantsCharacteristicsTeledentistry Group(n = 14)Standard Group(n = 13)p value aAge: Mean ± SD50.4 ± 14.249.9 ± 15.70.931bFemale: n (%)6 (42.9)3 (23.1)0.420Marital status: n (%)0.236 Unmarried7 (50.0)10 (76.9) Married7 (50.0)3 (23.1)Health care scheme: n (%)1.000 CSMBS5 (35.7)4 (30.8) SSS 2 (14.3)2 (15.4) UCS7 (50.0)7 (53.8)Tumor stage c: n (%)0.710 Stage I0 (0.0)2 (15.4) Stage II5 (35.7)5 (38.5) Stage III3 (21.4)2 (15.4) Stage IVA2 (14.3)2 (15.4) Stage IVB4 (28.6)2 (15.4)Tumor site: n (%)0.648 Oropharynx1 (7.1)2 (15.4) Nasopharynx6 (42.9)6 (46.2) Tongue2 (14.3)1 (7.7) Lymphoma3 (21.4)2 (15.4) Salivary gland2 (14.3)0 (0.0) Larynx0 (0.0)2 (15.4)Radiation dosage > 60 Gy: n (%)11 (78.6)11 (84.6)1.000Cancer treatment: n (%)1.000 Radiotherapy4 (28.6)4 (30.8) Radiochemotherapy10 (71.4)9 (69.2)Number of teeth: Mean ± SD22.2 ± 5.123.0 ± 5.60.701bMucositis: n (%)0.823 03 (21.4)2 (15.4) I4 (28.6)6 (46.2) II6 (42.9)4 (30.8) III1 (7.1)1 (7.7)Xerostomia: n (%)0.566 00 (0.0)1 (7.7) I5 (35.7)6 (46.2) II8 (57.1)6 (46.2) III1 (7.1)0 (0.0)Maximal mouth opening:Mean ± SD (mm.)36.1 ± 9.635.5 ± 7.50.860b ≤ 35 mm.: n (%)8 (57.1)5 (38.5)0.450a Fisher’s exact test, b Independent t-test, c American Joint Committee on Cancer’s Cancer Staging Manual, 7th edition25SD Standard deviation, CSMBS Civil Service Medical Benefits Scheme, SSS Social Security Scheme, UCS Universal Coverage Scheme Table 1Baseline characteristics of the study participantsCharacteristicsTeledentistry Group(n = 14)Standard Group(n = 13)p value aAge: Mean ± SD50.4 ± 14.249.9 ± 15.70.931bFemale: n (%)6 (42.9)3 (23.1)0.420Marital status: n (%)0.236 Unmarried7 (50.0)10 (76.9) Married7 (50.0)3 (23.1)Health care scheme: n (%)1.000 CSMBS5 (35.7)4 (30.8) SSS 2 (14.3)2 (15.4) UCS7 (50.0)7 (53.8)Tumor stage c: n (%)0.710 Stage I0 (0.0)2 (15.4) Stage II5 (35.7)5 (38.5) Stage III3 (21.4)2 (15.4) Stage IVA2 (14.3)2 (15.4) Stage IVB4 (28.6)2 (15.4)Tumor site: n (%)0.648 Oropharynx1 (7.1)2 (15.4) Nasopharynx6 (42.9)6 (46.2) Tongue2 (14.3)1 (7.7) Lymphoma3 (21.4)2 (15.4) Salivary gland2 (14.3)0 (0.0) Larynx0 (0.0)2 (15.4)Radiation dosage > 60 Gy: n (%)11 (78.6)11 (84.6)1.000Cancer treatment: n (%)1.000 Radiotherapy4 (28.6)4 (30.8) Radiochemotherapy10 (71.4)9 (69.2)Number of teeth: Mean ± SD22.2 ± 5.123.0 ± 5.60.701bMucositis: n (%)0.823 03 (21.4)2 (15.4) I4 (28.6)6 (46.2) II6 (42.9)4 (30.8) III1 (7.1)1 (7.7)Xerostomia: n (%)0.566 00 (0.0)1 (7.7) I5 (35.7)6 (46.2) II8 (57.1)6 (46.2) III1 (7.1)0 (0.0)Maximal mouth opening:Mean ± SD (mm.)36.1 ± 9.635.5 ± 7.50.860b ≤ 35 mm.: n (%)8 (57.1)5 (38.5)0.450a Fisher’s exact test, b Independent t-test, c American Joint Committee on Cancer’s Cancer Staging Manual, 7th edition25SD Standard deviation, CSMBS Civil Service Medical Benefits Scheme, SSS Social Security Scheme, UCS Universal Coverage Scheme Baseline characteristics of the study participants Maximal mouth opening: Mean ± SD (mm.) a Fisher’s exact test, b Independent t-test, c American Joint Committee on Cancer’s Cancer Staging Manual, 7th edition25 SD Standard deviation, CSMBS Civil Service Medical Benefits Scheme, SSS Social Security Scheme, UCS Universal Coverage Scheme The primary outcome analysis revealed mean differences of 1.9% points (95% CI [− 8.6, 12.4]) for the PI, and − 2.2% points (95% CI [− 17.2, 12.8]) for BOP at the post 6-month follow-up visit (Table 2). These results suggest that teledentistry was noninferior to standard follow-up, as the upper CI limits crossed the line of no effect (zero) but remained within the predefined noninferiority margin of 15% (Fig. 2). Fig. 2Noninferiority analyses of the mean differences in the PI, BOP, and OHIP-14 between the teledentistry and standard groups Noninferiority analyses of the mean differences in the PI, BOP, and OHIP-14 between the teledentistry and standard groups Table 2Analysis of the continuous outcomesOutcomeTeledentistry Group (n = 14)Standard Group (n = 13)Mean difference#[95% CI]BaselinePost-F/UBaselinePost-F/UPI (%): mean ± SD79.0 ± 21.780.1 ± 17.687.1 ± 7.182.3 ± 13.61.9 [-8.6, 12.4]BOP (%): mean ± SD44.7 ± 25.950.9 ± 23.634.5 ± 20.248.6 ± 19.8−2.2 [− 17.2, 12.8]OHIP-14 (%): mean ± SD36.5 ± 19.325.6 ± 14.640.0 ± 25.617.3 ± 15.79.0 [− 2.2, 20.2]Satisfaction: mean ± SD4.0 ± 0.04.0 ± 0.04.0 ± 0.04.0 ± 0.00.0 [0.0, 0.0]Baseline within 1 week after completing radiotherapy, Post-F/U Post 6-month follow-up visit, CI Confidence interval, SD Standard deviation, PI Plaque index, BOP Bleeding on probing, OHIP-14 Oral Health Impact Profile#Adjusted between-group differences at the post 6-month follow-up visit were estimated using analysis of covariance (ANCOVA), with baseline values as covariates Table 2Analysis of the continuous outcomesOutcomeTeledentistry Group (n = 14)Standard Group (n = 13)Mean difference#[95% CI]BaselinePost-F/UBaselinePost-F/UPI (%): mean ± SD79.0 ± 21.780.1 ± 17.687.1 ± 7.182.3 ± 13.61.9 [-8.6, 12.4]BOP (%): mean ± SD44.7 ± 25.950.9 ± 23.634.5 ± 20.248.6 ± 19.8−2.2 [− 17.2, 12.8]OHIP-14 (%): mean ± SD36.5 ± 19.325.6 ± 14.640.0 ± 25.617.3 ± 15.79.0 [− 2.2, 20.2]Satisfaction: mean ± SD4.0 ± 0.04.0 ± 0.04.0 ± 0.04.0 ± 0.00.0 [0.0, 0.0]Baseline within 1 week after completing radiotherapy, Post-F/U Post 6-month follow-up visit, CI Confidence interval, SD Standard deviation, PI Plaque index, BOP Bleeding on probing, OHIP-14 Oral Health Impact Profile#Adjusted between-group differences at the post 6-month follow-up visit were estimated using analysis of covariance (ANCOVA), with baseline values as covariates Analysis of the continuous outcomes Baseline within 1 week after completing radiotherapy, Post-F/U Post 6-month follow-up visit, CI Confidence interval, SD Standard deviation, PI Plaque index, BOP Bleeding on probing, OHIP-14 Oral Health Impact Profile #Adjusted between-group differences at the post 6-month follow-up visit were estimated using analysis of covariance (ANCOVA), with baseline values as covariates Regarding radiotherapy-related oral complications, no increase in mucositis severity was observed in either group. In addition, the incidence of osteoradionecrosis demonstrated noninferiority (risk difference: −0.15; 95% CI [− 0.35, 0.04]) (Table 3; Fig. 3). The satisfaction scores were consistently high, with all participants in both groups reporting the highest possible scores from baseline through to the final assessment. Fig. 3Noninferiority analyses of the risk differences in radiotherapy-related oral complications between the teledentistry and standard groups Noninferiority analyses of the risk differences in radiotherapy-related oral complications between the teledentistry and standard groups Table 3Analysis of the categorical outcomesOutcomeTeledentistry Group (n = 14)Standard Group (n = 13)Risk difference [95% CI]Post-F/UPost-F/UDC incidence: n (%)3 (21.4)2 (15.4)0.07 [− 0.23, 0.35]Lower MMO: n (%)2 (14.3)3 (23.0)−0.09 [− 0.38, 0.21]Increased MS: n (%)0 (0.0)0 (0.0)0.00 [0.00, 0.00]Increased XS: n (%)2 (14.3)1 (7.7)0.07 [− 0.17, 0.30]ORN incidence: n (%)0 (0.0)2 (15.4)−0.15 [− 0.35, 0.04]Post-F/U Post 6-month follow-up visit, CI Confidence interval, DC Dental caries, MMO Maximum mouth opening, MS Mucositis severity, XS Xerostomia severity, ORN Osteoradionecrosis Table 3Analysis of the categorical outcomesOutcomeTeledentistry Group (n = 14)Standard Group (n = 13)Risk difference [95% CI]Post-F/UPost-F/UDC incidence: n (%)3 (21.4)2 (15.4)0.07 [− 0.23, 0.35]Lower MMO: n (%)2 (14.3)3 (23.0)−0.09 [− 0.38, 0.21]Increased MS: n (%)0 (0.0)0 (0.0)0.00 [0.00, 0.00]Increased XS: n (%)2 (14.3)1 (7.7)0.07 [− 0.17, 0.30]ORN incidence: n (%)0 (0.0)2 (15.4)−0.15 [− 0.35, 0.04]Post-F/U Post 6-month follow-up visit, CI Confidence interval, DC Dental caries, MMO Maximum mouth opening, MS Mucositis severity, XS Xerostomia severity, ORN Osteoradionecrosis Analysis of the categorical outcomes Post-F/U Post 6-month follow-up visit, CI Confidence interval, DC Dental caries, MMO Maximum mouth opening, MS Mucositis severity, XS Xerostomia severity, ORN Osteoradionecrosis In contrast, the CIs for the OHIP-14 scores (Table 2) and other radiotherapy-related oral complications (Table 3) crossed both the noninferiority margin and the line of no effect, rendering these outcomes inconclusive (Figs. 2 and 3). Using a 10-point threshold to define clinically meaningful change in OHIP-14 scores, 5 of 14 participants (35.7%) in the teledentistry group showed improvement, 8 (57.1%) remained stable, and 1 (7.1%) worsened. In the standard group, 6 of 13 participants (46.2%) improved and 7 (53.8%) remained stable. Descriptive changes in individual OHIP-14 item scores from baseline to follow-up in both groups are presented in Supplementary Table S1. During the 6-month follow-up period, no new dental caries were clinically observed in either group. No cases of osteoradionecrosis were identified in the teledentistry group, whereas two participants in the standard group developed osteoradionecrosis. The diagnostic performance of complication assessment at the last follow-up visit, compared with the clinical outcome assessment at the post 6-month follow-up visit, is summarized in Supplementary Table S2. Comparable patterns were observed between the teledentistry and standard groups, with high agreement for mucositis and trismus, and lower sensitivity for dental caries and xerostomia in both groups. Additional data from the post 6-month follow-up visit for clinical outcome assessment are presented in Supplementary Table S3. Unscheduled dental visits were infrequent: one participant in the teledentistry group required an unscheduled visit due to acute periodontitis, while two participants in the standard group each required one additional visit related to osteoradionecrosis. Discussion This is the first study to evaluate the noninferiority of teledentistry compared with standard in-person follow-up in terms of oral health of HNC survivors following radiotherapy. The results demonstrate that teledentistry was noninferior and represents a feasible alternative to standard in-person follow-up during the six months following radiotherapy for monitoring oral health in this patient population. This approach may also offer benefits such as reduced healthcare costs and time savings, as reported in the literature [13, 14]. The noninferior results observed for both PI and BOP in Table 2; Fig. 2 indicate that teledentistry may support maintenance of oral hygiene and gingival health at levels comparable to standard in-person follow-up during the early post-radiotherapy period. Through visual assessment and individualized guidance, remote follow-up appears to encourage self-care behaviors similar to those achieved through standard in-person visits. This is particularly relevant for patients with HNC, who may experience treatment-related challenges that affect their ability to maintain oral health. Even though the absolute PI and BOP values remained relatively high in both groups, this finding likely reflects the substantial oral health challenges experienced by patients with HNC following radiotherapy, including xerostomia, mucosal discomfort, and reduced oral function. The feasibility of teledentistry in this study was supported by the combined use of live video and self-photography using a smartphone. Based on the experience of our research team (SP and WW), although some participants were initially unable to capture clinically interpretable intraoral images, the ability to provide iterative feedback—through resubmission and real-time guidance during video consultations—improved image quality over time. In addition, live video consultations offered a unique advantage over in-clinic visits by allowing participants to display their actual oral hygiene practices, instruments, and home environment, enabling more tailored and context-specific guidance. The adequacy of remote assessments was further supported by the diagnostic performance data (Supplementary Table S2), which demonstrated high agreement for conditions such as mucositis and trismus, and consistently high specificity across outcomes, indicating reliable identification of disease absence. Although sensitivity was lower for certain conditions, this reflects inherent limitations of the assessment methods rather than issues with feasibility. The reduced sensitivity for dental caries may be attributable to differences in assessment methods observed in both the teledentistry and standard groups, as radiographic evaluation was performed only during the final clinical outcome assessment at the post–6-month follow-up visit in the dental clinic. Similarly, the lower sensitivity observed for xerostomia may reflect variability in grading, which incorporates subjective patient-reported symptoms and may result in inter-examiner differences between the clinical examiners. Although the findings on oral health–related quality of life were inconclusive (Table 2; Fig. 2), the distribution of clinically meaningful changes suggests a favorable pattern, with a substantial proportion of participants showing improvement or remaining stable and very few worsening. Examining patterns of change provides additional context beyond mean scores when interpreting patient-reported outcomes [33]. These patterns were similar between groups and should be interpreted cautiously, as the analysis of clinically meaningful change was descriptive and not intended for formal comparison between groups. This overall trend is consistent with previous research indicating that remote care can support quality of life in patients with cancer. For example, a systematic review by da Silva et al. showed that telehealth interventions are feasible and may positively influence patient-reported outcomes in individuals with HNC by improving their self-efficacy, sense of personal control, and health knowledge while maintaining acceptable diagnostic accuracy compared with in-person care [35]. A related meta-analysis also confirmed that telehealth interventions can improve cancer survivors’ quality of life, with the use of application-based interventions being the most effective approach [36]. Our findings on some radiotherapy-related oral complications were inconclusive (Table 3; Fig. 3), which may be due to the small sample sizes for these outcomes. The relatively low incidence of several oral complications observed in this study should be interpreted in the context of the early post-radiotherapy period. Although the first 6 months are characterized by dynamic changes in oral health, the occurrence and severity of complications may vary over time. For example, mucositis tends to improve after treatment, whereas conditions such as osteoradionecrosis and trismus may begin to develop but often remain limited in incidence during this period. Additionally, all participants were rendered dentally fit prior to radiotherapy, which may have reduced the early occurrence of dental caries despite the increased risk associated with reduced salivary flow. The predominance of non-oral primary tumor sites may have further contributed to the lower burden of oral complications. Radiotherapy-related oral complications, such as xerostomia and limited mouth opening, can affect chewing and swallowing, and there is evidence that targeted rehabilitation can improve these functions. For instance, Dai et al. demonstrated that a telehealth-based program grounded in behavior change theory was effective in improving or maintaining maximal mouth opening in patients undergoing radiotherapy for HNC [37]. Similarly, a recent systematic review by Yang et al. showed that home-based telehealth interventions can improve swallowing and reduce dysphagia severity in this population [38]. Together, these findings suggest that structured remote monitoring, combined with rehabilitation, may help address functional impairments. Notably, the included participants reported high levels of satisfaction and engagement with teledentistry as a follow-up option for HNC care. This was observed even when teledentistry was introduced shortly after radiotherapy, a period often characterized by active complications. These outcomes are consistent with those of previous studies and systematic reviews showing that telehealth worked well in HNC care, other cancer populations, and related areas such as swallowing rehabilitation [13, 35, 38–40]. However, the uniform satisfaction scores (100% maximum ratings) in this study may reflect social desirability bias or measurement limitations of the single-item questionnaire. Future studies are needed to confirm these findings and should employ validated, multi-item instruments to provide a more comprehensive and reliable assessment of patient satisfaction. Limitations Several limitations of this study should be acknowledged. First, this was a single-center study with a small sample size, which was calculated based on the primary outcomes. These factors potentially limit the generalizability of the findings and the statistical power to detect significant differences in secondary outcomes. Accordingly, while the study was adequately powered for the primary outcomes, the secondary outcome results were underpowered and should be interpreted with caution. In addition, the wide CIs observed for several outcomes reflect limited precision and a potential risk of type II error, suggesting that larger studies are needed to confirm these findings. The estimates for secondary outcomes may inform, but should not be used as the sole basis for, future sample size calculations. Second, although the statistical tests showed no significant differences in the baseline characteristics, the small sample size may have masked meaningful imbalances. For example, tumors tended to be more severe in the patients in the teledentistry group, which could have increased the risk of complications and reduced the patients’ ability to maintain oral health. Conversely, the patients in the teledentistry group had slightly fewer teeth, which may have increased their ability to maintain oral health. Third, patient satisfaction was assessed using a single-item, non-validated questionnaire, which may have limited discriminatory capacity and contributed to a ceiling effect, as reflected by uniformly high scores. The lack of established validity and reliability also limits confidence in this outcome. Although this measure was predefined in the study protocol, the findings should be interpreted with caution. Fourth, the follow-up model was limited to the first 6 months after radiotherapy, a period with typically higher follow-up needs. While appropriate for the early post-treatment phase, its feasibility in other settings may vary depending on local resources and care practices. Therefore, caution is warranted when generalizing this model to other institutions. Finally, we performed a per-protocol analysis because one participant died from a cause unrelated to the study before the endpoint. This approach may have introduced bias because it excluded participants who did not complete the follow-up. Clinical implications Because the study was conducted during the first six months after the completion of radiotherapy—a period of heightened care needs—the findings support the integration of teledentistry into early survivorship follow-up care for HNC patients. Teledentistry can improve access to healthcare, facilitate the timely identification of developing issues, and enhance patient engagement. These benefits are valuable for individuals who face transportation, financial, and/or functional challenges regarding attending in-person follow-up appointments. However, teledentistry should not be considered a replacement for conventional face-to-face dental care. In-person visits remain essential for professional oral hygiene procedures and comprehensive clinical examinations. Therefore, even within a teledentistry-supported model, patients should continue to receive periodic in-person assessments. In addition, the implementation of teledentistry requires careful consideration of patient capability and accessibility. The requirement for patients to capture multiple intraoral photographs may present challenges, particularly for individuals with limited digital literacy, physical constraints, or disease-related impairments. As such, appropriate training and support should be provided prior to enrollment, and patients should demonstrate the ability to perform these tasks reliably. Importantly, some vulnerable populations—especially those with lower socioeconomic status or limited health and technological literacy—may be less able to engage with teledentistry-based care, potentially exacerbating existing disparities. These factors should be considered when selecting suitable candidates for this approach. Combining structured remote monitoring with periodic in-person assessment may provide a practical, patient-centered strategy that promotes adherence and ensures comprehensive care. To illustrate, a hybrid model that alternates teledentistry with in-person visits could be adopted for the recommended three-monthly dental follow-up schedule [5]. Patients could attend an in-person appointment during the first 3 months, when complications are most active, and this could be followed by a teledentistry appointment during the next 3-month interval and another in-person appointment during the third 3-month interval. This approach reduces the burden associated with frequent clinic visits while maintaining the clinical oversight necessary to address emerging oral health concerns. It is also consistent with emerging survivorship care frameworks, including those proposed by the European Society for Medical Oncology, which emphasize patient empowerment, supported self-management, and the strategic use of digital tools (e.g., remote monitoring) to enhance continuity and quality of care [41]. Further studies are needed to validate this model, including evaluation of long-term outcomes and cost-effectiveness. Conclusions We have shown that a teledentistry-based follow-up approach may be a feasible tool for monitoring oral health in patients with head and neck cancer during the first 6 months after radiotherapy. Our findings indicate that this approach, incorporating live video consultations with smartphone-based oral photography, showed oral health outcomes comparable to those of standard in-person follow-up visits, based on PI and BOP assessments performed during in-person evaluations. Further studies are warranted to confirm the generalizability of these findings and to more robustly evaluate secondary outcomes, as well as to explore implementation strategies, including how teledentistry could be integrated into long-term survivorship care through hybrid approaches. Supplementary Information Supplementary Material 1. Supplementary Material 1.